Tulsi and Nutmeg undergoes hepatic first pass, hence it shows very poor bioavailability. By creating a pH-induced in-situ gel, the formulation for this study aims to increase bioavailability. Mucoadhesive polymer in the gel reduces mucociliary clearance, increasing the gel's contact with the nasal mucosa and, ultimately, improving drug absorption. Carbopol 940, which has the ability to produce gelation due to pH, was utilized to accomplish in situ gelation, while HPMC E15 and HPMC 15cps were employed as the Mucoadhesive agents. Gels were made by Gelation research, Gel strength, Permeation studies,pH, Drug Content, drug polymer interaction, and Stability study are characteristics of the previously described cold technique.In an in-vitro drug release investigation, the drug content ranged from 91.30 to 97.13%, and the gel's pH ranged from 5 to 5.9.A rheological analysis of the gel formulation revealed that the viscosity increases with an increase in polymer concentration and that the gel strength ranged from 25 to 41.seconds. The results of the stability research show that the Tulsi and Nutmeg did not alter significantly. When administered via the nasal route, Tulsi and Nutmeg in a pH-induced, bioadhesive solution may be able to prevent the first pass impact that comes with taking it orally, improving the drugâs bioavailability and providing a safe, long-lasting release nasal delivery method for depression management.From the above results it can be concluded that Tulsi and Nutmeg was successfully formulated as a pH induced in situ nasal gelling system using Carbapol 940, HPMC E15 and HPMC 15cps. The optimized formulation F1 provided sustain in vitro release of drug over an extended period of 8hrs.
